Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-08 · accession 0000899243-21-039857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-12 | 2021-10-08+ | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $56.34 | -48.0K | 475.1K | -9% | -$2.70M |
| DM | 2021-10-12 | 2021-10-08+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +48.0K | 505.7K | +10% | +$99.8K |
| DM | 2021-10-12 | 2021-10-08+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -48.0K | 35.2K | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-08 | S | D | 7,920 | $59.28 | 465,140 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.90 to $59.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-10-08 | S | D | 670 | $60.32 | 464,470 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.91 to $60.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-10-08 | S | D | 271 | $61.87 | 464,199 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-11 | M | A | 6,456 | $2.08 | 470,655 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-11 | S | D | 5,712 | $53.58 | 464,943 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.19 to $54.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2021-10-08 | S | D | 2,078 | $57.29 | 473,060 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.20 to $58.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2021-10-11 | S | D | 744 | $54.50 | 464,199 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.28 to $54.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2021-10-08 | S | D | 21,236 | $55.56 | 484,507 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.10 to $56.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2021-10-08 | M | A | 41,544 | $2.08 | 505,743 | D | — | — | |
| 10 | Common | Common Stock | 2021-10-08 | S | D | 9,369 | $56.82 | 475,138 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.19 to $57.185. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-10-11 | M | D | 6,456 | $0.00 | 28,725 | D | $2.08 · — to 2029-11-13 | 6,456 Common Stock | (F9) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |
| 12 | Derivative | Stock Option (Right to Buy) | 2021-10-08 | M | D | 41,544 | $0.00 | 35,181 | D | $2.08 · — to 2029-11-13 | 41,544 Common Stock | (F9) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |